Israel Englander Cognition Therapeutics Inc Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
50Shares Held
13.4MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$2.7 Million4.39% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$992,4190.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$557,8050.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI614KShares$276,5200.01% of portfolio
-
Voss Capital, LLC Houston, TX500KShares$225,0000.03% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $10.2M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...